Close Menu

NEW YORK – Molecular diagnostics maker Applied BioCode announced yesterday that it has submitted a syndromic panel assay to detect respiratory pathogens to the US Food and Drug Administration for potential 510(k) clearance.

The Applied BioCode Respiratory Pathogens Panel (RPP) detects 20 common viruses and bacteria that can cause upper respiratory infections from nasopharyngeal swab samples with the firm's MDx-3000 instrument.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.